Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.76 USD
-0.01 (-1.38%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $0.76 0.00 (-0.03%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.43 | 1.58 | 9.99 |
Current Quarter Estimate | -0.26 | -1.22 | 61.00 |
Year Ago Quarter Estimate | -0.30 | -0.07 | 54.84 |
Next Quarter Estimate | -0.25 | -1.93 | 63.00 |
Next Year Estimate | -0.66 | 12.53 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 25.60 | 20.10 | 15.67 |
Next Year | 29.03 | 15.20 | 11.34 |
Last 5 Years | NA | 7.90 | 8.10 |
Next 5 Years | NA | 21.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.93 |
Price/Book (MRQ) | NA | 1.61 |
Price/Cash Flow (MRFY) | NA | 9.71 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -61.73% | -58.89% |
Return on Equity (TTM) | NA | -58.99% |
Debt to Equity (MRQ) | -1.45 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.